Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06061393

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin <9 gr/dl , treated with venofer and women treated with ferinject.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Anemia, Iron Deficiency Anemia Anemia, Hypochromic Anemia, Iron-Deficiency Hematologic Diseases Hemic and Lymphatic Diseases Iron Deficiencies Iron Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Pregnancy Anemia

Age range

18 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Galilee Medical Center

Nahariya, Israel

Location status: Recruiting

Location contact

Maya Wolf, MD

CONTACT

972-507887800

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

pregnancy>24 weeks of gestation anemia with Hb<9 anemia with Hb<9.5 if symptomatic anemia or previous postpartum hemorrhage

Exclusion criteria

  • Allergy to one of the study's drugs
  • IV iron treatment in the last month
  • Underlying medical conditions associated with anemia, such as thalassemia Major, renal insufficiency, or spherocytosis
  • Twin pregnancy
  • non iron deficiency anemia

Treatment and study plan

Venofer 200 MG Per 10 ML Injection

Drug

treat anemia with venofer up to 5 doses

Ferinject

Drug

ferinject 500 mg, once a week for 2 weeks

Primary outcomes

  1. ratio of women with Hb level >11 at delivery

    Time frame: at delivery

    Hb level

  2. postpartum Hb level

    Time frame: during 48 hours after delivery

    gr/dl

Study contacts

Contact information is provided by the study sponsor or research team.

maya Wolf, MD

CONTACT

[email protected]

972507887800

Sponsors and collaborators

Lead sponsor

Western Galilee Hospital-Nahariya

Other Gov

Registry information

Official study title

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia (Hb<9)

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Sep 29, 2023
Registry last updated
Sep 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.